An N-of-1 trial is defined as a prospective, multiple crossover trial in a single patient. If randomization of the treatment sequence and replication across patients is included in the trial design, then it results in “replicated N-of-1 RCTs”. In the webinar, we will demonstrate one approach to the statistical analysis of data collected in N-of-1 RCTs based on the randomization of the treatment sequence, which is both simple and sound. Furthermore, several meta-analytical options for the statistical comparison and aggregation of the replications will be presented.
The registration is mandatory and until 29 June 2023 at 11:45 p.m.
The workshop is open to the international research community, clinicians, medical specialists, healthcare professionals and advocacy patient groups with knowledge on the RD Clinical Trials.
More information here.